| # | Drug | Count |
|---|---|---|
| 0 | VANDETANIB | 32 |
| 1 | TIRZEPATIDE | 17 |
| 2 | LIRAGLUTIDE | 13 |
| 3 | CABOZANTINIB | 10 |
| 4 | LEVOTHYROXINE SODIUM | 10 |
| 5 | SELPERCATINIB | 7 |
| 6 | DULAGLUTIDE | 6 |
| 7 | PRALSETINIB | 6 |
| 8 | DENOSUMAB | 5 |
| 9 | METHOTREXATE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANDETANIB | 32 | 0.0176 |
| 1 | PRALSETINIB | 6 | 0.0033 |
| 2 | LAROTRECTINIB | 1 | 0.0011 |
| 3 | ENTRECTINIB | 1 | 0.0006 |
| 4 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0004 |
| 5 | BISMUTH SUBSALICYLATE | 2 | 0.0004 |
| 6 | ZIPRASIDONE | 1 | 0.0003 |
| 7 | LIRAGLUTIDE | 13 | 0.0003 |
| 8 | RISDIPLAM | 1 | 0.0002 |
| 9 | ZANUBRUTINIB | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bismuth [EPC] | 2 | 0.0004 |
| 1 | Vitamin D3 Analog [EPC] | 3 | 0.0001 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 5 | GLP-1 Receptor Agonist [EPC] | 42 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Penem Antibacterial [EPC] | 1 | 0.0000 |